The Business of Alt Protein: Finding and financing biomanufacturing capacity
Event description
Join GFI and Synonym, a company developing, financing and building commercial-scale biomanufacturing infrastructure, to learn about locating production capacity and how to think about biomanufacturing project finance as a way to bring more capacity online. We’ll cover:
- The current state of biomanufacturing capacity and how to use Capacitor to locate existing capacity.
- The benefits of off-balance-sheet financing for large-scale biomanufacturing infrastructure projects.
- Attracting investors for large-scale biomanufacturing infrastructure projects by understanding acceptable risk.
- The project finance and project development process.
- Common pitfalls of large-scale infrastructure projects that limit bankability.
About Synonym
Synonym is accelerating the world’s biological future by developing, financing, and building commercial-scale biomanufacturing facilities. They provide synthetic biology (synbio) producers – from startups to the Fortune 500 – with flexible production capacity while giving infrastructure investors access to a new, carbon-negative biomanufacturing asset class that they are calling “fermentation farms”.
Upcoming events
View all events
The Business of Alt Protein: What founders need to know about M&A for mission-driven companies
Join GFI for a Business of Alt Protein webinar featuring a presentation from Tuck Advisors on mergers and acquisitions for mission driven companies.
The Science of Alt Protein: Nature and nurture—Cell lines and media
Discover opportunities for the convergent development of both cell lines and media for cultivated meat.
